Analog Devices, Moet Hennessy, UC Davis Collaborate on Wine Quality Technology

MT newswire2026/10/07 13:55

09:55 AM EDT, 10/07/2026 (MT Newswires) -- Analog Devices (ADI), LVMH's wines and spirits division, Moet Hennessy, and the University of California, Davis, said Wednesday they are collaborating on technology aimed at improving wine quality and supporting vineyard health. The effort will explore the use of Analog Devices' chemical-sensing technology to detect and interpret volatile chemical signatures from grapevines, juice and wine. The technology is expected to provide viticulture and winemaking teams with earlier insight into biological processes and potential quality risks, according to a joint statement. The companies said the technology identified samples at elevated risk of developing Fresh Mushroom Aroma, a wine-quality defect, before it would traditionally be detected. Price: 407.49, Change: -13.06, Percent Change: -3.11

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Simwon America (SWA.US) applies for Nasdaq IPO, plans to raise up to $50 million

Simwon America, a manufacturer of structural components for electric vehicles, filed for an IPO with the U.S. Securities and Exchange Commission (SEC) last Friday, aiming to raise up to $50 million. The company is a spinoff of Korea’s MS Autotech.

智通财经•2026/10/12 07:43

Sui Foundation Invests $30M in DATA Network as It Moves to Sui post-167040 post-167040 post-167040

Newscrypto•2026/10/12 07:18

Equities: Stable oil and yields support stock gains - Danske Bank

FXStreet•2026/10/12 07:12

Dental caries treatment provider vVardis (VVVV.US) submits US IPO application, expected to raise 200 million USD

vVardis Holding filed for an initial public offering (IPO) with the U.S. Securities and Exchange Commission (SEC) last Friday. The company focuses on self-developed non-invasive restorative therapies for the early treatment of dental caries. The IPO is expected to raise 200 millions USD.

智通财经•2026/10/12 07:07